Mark Josephson and the ICD: A Personal Perspective.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28507741)

Published in Arrhythm Electrophysiol Rev on April 01, 2017

Authors

Charles D Swerdlow1

Author Affiliations

1: Cedars-Sinai Medical Center, Los Angeles, USA.

Articles cited by this

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation (2008) 8.94

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med (2016) 7.87

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol (2008) 3.58

Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol (2006) 1.68

The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures. Ann Intern Med (1986) 1.03

The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med (2000) 0.99

Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms. Am J Cardiol (1999) 0.87

All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator. Circulation (2007) 0.82

Use of the automatic implantable cardioverter-defibrillator. N Engl J Med (1986) 0.81